Stock Warrants - summary of all warrant activity (Details) - $ / shares |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Stock Warrants | ||
| Number of Warrants, Beginning balance | 1,428,600 | |
| Number of Warrants, Granted | 1,938,600 | |
| Number of Warrants, Exercised | (510,000) | |
| Number of Warrants, Ending balance | 1,428,600 | 1,428,600 |
| Weighted Average Exercise Price, Beginning balance | $ 2 | |
| Weighted Average Exercise Price, Granted | $ 1.47 | |
| Weighted Average Exercise Price, Exercised | 0.0001 | |
| Weighted Average Exercise Price, Ending balance | $ 2 | $ 2 |
| Weighted Average Remaining Contractual Life (in years) | 4 years 6 months | 4 years 8 months 26 days |
| Weighted Average Remaining Contractual Life, Granted (in years) | 4 years 8 months 26 days |
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards granted excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Number of share warrants exercised during the period. No definition available.
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans are exercise in period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|